Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:41:38.454Z.
Calculation as of: 2026-10-06T16:41:38.454Z.
Quote observation: 2026-10-06T16:40:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f13a1340446ed9d2fab2f71bf594eb69a7c02e94fe434461414907d992f5ed7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Cullinan Therapeutics, Inc.
Market Cap
$1.05B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.06B
Free Cash Flow Yield
21.19%
TTM Avg
18.91%
3Y Avg
16.36%
5Y Avg
12.15%
Market Cap
$1.04B
Free Cash Flow Yield
N/A
TTM Avg
3.10%
3Y Avg
4.04%
5Y Avg
3.98%
Market Cap
$1.04B
Free Cash Flow Yield
N/A
TTM Avg
0.18%
3Y Avg
0.18%
5Y Avg
0.18%
Market Cap
$1.04B
Free Cash Flow Yield
N/A
TTM Avg
2.53%
3Y Avg
3.77%
5Y Avg
3.64%
Market Cap
$1.04B
Free Cash Flow Yield
N/A
TTM Avg
17.35%
3Y Avg
119.04%
5Y Avg
59.35%
Market Cap
$1.03B
Free Cash Flow Yield
3.09%
TTM Avg
2.95%
3Y Avg
2.95%
5Y Avg
2.95%
Market Cap
$1.09B
Free Cash Flow Yield
2.29%
TTM Avg
1.62%
3Y Avg
1.72%
5Y Avg
1.76%
Market Cap
$1.09B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | $1.05B | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.06B | 21.19% | 18.91% | 16.36% | 12.15% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | N/A | 3.10% | 4.04% | 3.98% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.04B | N/A | 0.18% | 0.18% | 0.18% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.04B | N/A | 2.53% | 3.77% | 3.64% |
| Immatics N.V. (IMTX)vs › | $1.04B | N/A | 17.35% | 119.04% | 59.35% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.03B | 3.09% | 2.95% | 2.95% | 2.95% |
| IRadimed Corporation (IRMD)vs › | $1.09B | 2.29% | 1.62% | 1.72% | 1.76% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| Replimune Group, Inc. (REPL)vs › | $1.10B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
